Director, US Policy and Advocacy

Iovance Biotherapeutics(1 month ago)

RemoteFull TimeDirector$169,726 - $226,510 (estimated)Policy and Advocacy

About this role

The Director, US Policy and Advocacy leads development and execution of advocacy and public policy strategies to shape the US policy environment for existing and pipeline cell therapies. The role partners with commercial, market access, forecasting, and executive teams to assess policy impacts, engage with federal and state policymakers and trade organizations, and support commercialization and patient access goals. This position reports to the Head of Policy, Pricing and Distribution and requires deep US healthcare reimbursement policy expertise.

View Original Listing

Required Skills

Policy Analysis
Advocacy
Coalition Building
Government Affairs
Reimbursement
Medicare Knowledge
Medicaid Knowledge
Trade Associations
Strategic Thinking
Regulatory Monitoring

+6 more

Qualifications

BA or BS Degree
Advanced Degree Preferred

About Iovance Biotherapeutics

iovance.com

Iovance Biotherapeutics is a clinical-stage biopharmaceutical company developing tumor-infiltrating lymphocyte (TIL) therapies that harness a patient’s own immune cells to recognize and kill diverse cancer cells. Its lead product, AMTAGVI (lifileucel), has received U.S. FDA accelerated approval for defined indications, and the company is advancing multiple clinical trials across solid tumors. Iovance builds and operates cell therapy manufacturing and Iovance Cell Therapy Centers to support production and commercialization, and partners with academic and industry collaborators to advance next‑generation T‑cell platforms. The company also provides patient resources, an expanded-access policy, and information about its pipeline and research.